Back to results
US 10,300,166 B2Granted
Degradable haemostat composition
AssigneeMedtrade Products Limited
InventorsCraig Hardy, Andrew Hoggarth, June Gladman
Life of this patent
Estimating the term…
Abstract
The present invention relates to a fibrous haemostat composition that is able to safely gradually and fully degrade in a human or animal body within about 30 days and so can be utilised by physicians to stem a flow of blood and promote healing both after as well as during surgical procedures.
Claims5
A method of manufacturing a haemostat composition, the method comprising:
- providing a chitosan salt or a chitosan derivative in a fibrous form:
- and
- combining it with a physiologically acceptable acid in an amount of acid that is from 25 to 70% by weight of the haemostat composition:
- wherein the haemostat composition is in a fibrous form and is able to fully degrade in a human or animal body within about 30 days.
1 more element
Dependencies are inferred from the claim text.